HRP-catalyzed signal enhancement that deposits 10–100× more chromophore at target sites–enabling FRET detection in clinical tissue samples where protein expression may be limited.
TSA exploits the catalytic activity of horseradish peroxidase (HRP) to amplify signal at target sites. HRP is conjugated to secondary antibodies that bind primary antibodies at protein targets.
When hydrogen peroxide is added with tyramide-chromophoreLoading... conjugates, HRP catalyzes the oxidation of tyramide, creating reactive intermediates that covalently bind to nearby tyrosine residues. This deposits 10–100× more chromophore than direct labeling methods.
How TSA Works: An enzyme (peroxidase) activates tyramide molecules, which deposit near the enzyme and become covalently attached to tissue. Each enzyme can activate many tyramide molecules, amplifying the signal.
Simple Analogy: Instead of one flag marking a location, TSA plants dozens—much easier to see, especially when the target is rare.
FRETLoading... detection requires sufficient chromophore density at target sites. In FFPELoading... clinical samples, antigen preservation varies and protein expression may be limited–direct labeling often produces insufficient signal.
TSA solves this by concentrating chromophore at the binding site, regardless of how much target protein is present. The covalent deposition creates stable, high-density labeling essential for reliable FRET measurements in clinical tissue.
The Challenge: In tissue samples, target proteins may be sparse. Without amplification, there might not be enough signal for reliable FRET detection.
The Solution: TSA increases signal while maintaining spatial specificity, enabling FRET measurement even with limited target abundance.
Both iFRET (immune-FRETLoading...) and aFRET (amplified FRETLoading...) rely on TSA to achieve detectable signal in tissue samples. The workflow involves sequential labeling: primary antibody ' HRP-secondary ' tyramide-donor chromophore, then repeating with the second target and acceptor chromophore.
This two-site approach with TSA amplification at each target creates the chromophore density needed for FRET detection at protein-protein interactionLoading... sites within the 1–10 nm range.
Implementation: QF-Pro uses TSA for the acceptor chromophore. This boosts acceptor signal while the donor signal comes from a different labeling strategy.
Result: Sufficient signal for FRET detection in standard FFPE clinical samples.
